Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898430-97-001625
Filing Date
1997-04-22
Accepted
1997-04-22 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF INC.BVF PARTNERS L.P.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 20289
2 AGREEMENT REGARDING JOINT FILING EX-99.A 1337
3 TRANSACTIONS IN THE STOCK BY THE REPORTING PERSONS EX-99.B 12012
  Complete submission text file 0000898430-97-001625.txt   35881
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

EIN.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45417 | Film No.: 97585285
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice